Stem cell transplantation in patients with high-risk AML in first remission - A low relapse rate and acceptable transplant-related mortality after intensification of the conditioning regimen with Re-188 labelled anti-CD66 monoclonal antibody

被引：0
|
作者：
Bunjes, D
Buchmann, I
Wiesneth, M
Von Harsdorf, S
Duncker, C
Kotzerke, J
Seitz, U
Dohr, D
Stefanic, M
Glatting, G
Buck, A
Grimminger, W
Schlenk, R
Munzert, G
Dreger, P
Bergmann, L
Doehner, H
Reske, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O327
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 30 条
  • [1] Low regimen related toxicity of radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation
    Hofmann, M
    Eder, M
    Dammann, E
    Börner, A
    Gieseke, M
    Franzke, A
    Stadler, M
    Heil, G
    Ganser, A
    Knapp, W
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S181 - S181
  • [2] Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia
    Koenecke, Christian
    Hofmann, Michael
    Bolte, Oliver
    Gielow, Peter
    Dammann, Elke
    Stadler, Michael
    Franzke, Anke
    Boerner, Anne Rose
    Eder, Matthias
    Ganser, Arnold
    Knapp, Wolfram
    Hertenstein, Bernd
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 87 (04) : 414 - 421
  • [3] Radioimmunotherapy with [188Re]-labelled anti-CD66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk acute myeloid leukemia
    Christian Koenecke
    Michael Hofmann
    Oliver Bolte
    Peter Gielow
    Elke Dammann
    Michael Stadler
    Anke Franzke
    Anne Rose Boerner
    Matthias Eder
    Arnold Ganser
    Wolfram Knapp
    Bernd Hertenstein
    International Journal of Hematology, 2008, 87 : 414 - 421
  • [4] 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia
    Bunjes, D
    LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2125 - 2131
  • [5] Radioimmunotherapy with rhenium-188 labelled anti CD 66 antibody in the conditioning for allogeneic stem cell transplantation for high-risk AML
    Bolte, O
    Hofmann, M
    Dammann, E
    Eder, M
    Boemer, AR
    Franzke, A
    Stadler, M
    Ganser, A
    Knapp, W
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2006, 37 : S116 - S116
  • [6] Radioimmunotherapy with 188Re labelled anti-CD66 antibody for myeloablation prior to stem cell transplantation in high risk leukemia patients.
    Buchmann, I
    Bunjes, D
    Kotzerke, J
    Seitz, U
    Glatting, G
    Rattat, D
    Martin, HJ
    Doehner, H
    Reske, SN
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 31P - 31P
  • [7] T-cell depleted allogeneic stem cell transplantation after intensified conditioning with Re-188 labelled anti-CD66 monoclonal antibody in patients with high-risk acute leukemia:: Long-term follow-up and factors affecting outcome.
    Bunjes, DW
    Buchmann, I
    Duncker, C
    Seitz, U
    Kotzerke, J
    Wiesneth, M
    Dohr, D
    Stefanic, M
    Von Harsdorf, S
    Buck, A
    Glatting, G
    Griminger, W
    Schlenk, R
    Munzert, G
    Bergmann, L
    Döhner, H
    Reske, SN
    BLOOD, 2001, 98 (11) : 197A - 197A
  • [8] 188 re-labeled anti-CD 66 monoclonal antibody as part of a reduced intensity conditioning regimen for patients at high risk of transplant-related mortality:: results of a pilot study of 12 patients
    Bunjes, D
    Buchmann, I
    Martin, H
    Hertenstein, B
    Wiesneth, M
    Ringhoffer, M
    Von Harsdorf, S
    Glatting, G
    Kotzerke, J
    Bergmann, L
    Reske, S
    Döhner, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S277 - S277
  • [9] Intensification of the conditioning regimen for high-risk AML patients with 188 Re-labeled anti-CD 66 monoclonal antibody:: final results of a phase I-II study
    Bunjes, D
    Wiesneth, M
    Buchmann, I
    Von Harsdorf, S
    Schlenk, R
    Seitz, U
    Kotzerke, J
    Duncker, C
    Stefanic, M
    Grimminger, W
    Dohr, D
    Buck, A
    Glatting, G
    Ringhoffer, M
    Zenz, T
    Bergmann, L
    Döhner, H
    Reske, S
    BONE MARROW TRANSPLANTATION, 2004, 33 : S32 - S32
  • [10] Intensification of the conditioning regimen for high-risk leukaemia with a 188 re-labelled anti-CD164b monoclonal antibody:: Results of a feasibility study.
    Bunjes, D
    Duncker, C
    Seitz, U
    Karakas, T
    Träger, H
    Stefanic, M
    Von Harsdorf, S
    Schirrmeister, H
    Kotzerke, J
    Reske, S
    Bergmann, L
    BLOOD, 1998, 92 (10) : 341B - 341B
123